← Open Payments lookup

FOLAWEWO AJAYI: Open Payments

NPI 1922632520 · GLOUCESTER CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$953 in 51 payments from 12 companies in 2025. Trend: 2023 $119 · 2024 $98 · 2025 $953

Food & beverage: $953
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$193
Alkermes, Inc.8$143
Vanda Pharmaceuticals Inc.5$93
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$88
Janssen Pharmaceuticals, Inc4$82
Otsuka America Pharmaceutical, Inc.3$75
E.R. Squibb & Sons, L.L.C.4$68
Lundbeck LLC3$56
Supernus Pharmaceuticals, Inc.3$48
Teva Pharmaceuticals USA, Inc.3$46

Products named: INGREZZA, REXULTI, ARISTADA, FANAPT, CAPLYTA, COBENFY, INVEGA, Qelbree.

Industry payments across NJ — which companies pay providers there.